Mucosal Immune Markers and Their Impact on Antimicrobial Resistance: A Systematic Review

Olabisi Lawal 1 * , Aliyu Olanrewaju Olaniyi 2, Uche Cyprain Tochukwu 3, Catherine Rono 4, Mayowa Josiah Badmus 5, Misbahudeen Olohuntoyin Abdulkareem 6, Udeichi Mmesoma Odinaka 7, Idris Olumide Orenolu 8, Udeichi Nnenna Chidimma 9
More Detail
1 University of Benin, Benin City,Nigeria
2 Stockport NHS foundation trust, Stepping Hill Hospital, Stockport, Manchester. United Kingdom.
3 Department of Epidemiology and Evidence-based Medicine. First Moscow State Medical University named after I. M Sechenov,Moscow Russia.
4 Department of Immunology; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
5 Faculty of Dentistry, Lagos University Teaching Hospital, Lagos, Nigeria.
6 Department of Internal Medicine, Kwara State University Teaching Hospital, Ilorin, Kwara State. Nigeria
7 Centre For Infectious Diseases, 68 Nigerian Army Reference Hospital Yaba. Lagos, Nigeria.
8 Infection Prevention and Control Saskatchewan Health Authority, Saskatchewan, Canada
9 Critical care department Iwosan Lagoon Hospital Ikoyi
* Corresponding Author
J CLIN MED KAZ, Volume 22, Issue 6, pp. 109-116. https://doi.org/10.23950/jcmk/17362
OPEN ACCESS 444 Views 68 Downloads
Download Full Text (PDF)
Author contributions: Conceptualization, O.P.L. and A.O.O.; methodology, O.P.L., A.O.O., U.C.T. and C. R.; validation, M.J.B., M.O.A. and U.M.O.; formal analysis, O.P.L.,A.O.O. and I.O.O.; investigation,O.P.L., U.C.T., and M.J.B.; resources, M.J.B. and I.O.O.; data curation, C.R. and M. O. A.; writing – original draft preparation,O.P.L., A.O.O., U.C.T. and C. R.; writing – review and editing, O.P.L., U.C.T., M.O.A.; visualization, C.R. and U.M.O.; supervision, O.P.L. and I. O.O.; project administration, O.P.L.; funding acquisition, O.P.L. All authors have  read and agreed to the published version of the manuscript.

Data availability statement: No datasets were generated or analysed during the current study.

Artificial Intelligence (AI) Disclosure Statement: AI-Unassisted Work.

ABSTRACT

Objectives: This systematic review aimed to evaluate the role of secretory immunoglobulin A (sIgA) and related mucosal immune markers in modulating susceptibility to colonization or infection by antimicrobial-resistant (AMR) bacteria in human and animal models.
Methods: Studies were included if they assessed mucosal sIgA levels about AMR outcomes, reported original data, and were published in English between 2015 and June 2025. Exclusion criteria included a lack of mucosal immune data or AMR-related endpoints. Databases searched included PubMed, ScienceDirect, and EBSCO (Knowledge and Library Hub), with the last search performed on June 10, 2025. The quality of the included studies was assessed using the checklist for quantitative studies, and data were extracted and synthesized narratively, stratified by immune markers, study design, and mucosal compartment.
Results: After the systematic search of the databases considered for this review and review of available literature indexed in them, eleven studies that met the inclusion criteria of this study were included in this review.  The mucosal sites investigated in most of these studies were gastrointestinal, respiratory, oral, and genitourinary mucosa. Of the eleven (11) studies, four carried out investigations in humans while the remaining seven utilized animal models. All the included studies reported secretory immunoglobulin A (sIgA) level, whereas five of the studies reported other indicators, such as cytokines and IgG, alongside sIgA levels. There was consistency in their results as increased sIgA levels were linked to decreased infection or colonization by AMR pathogens. Moreover, vaccination-based interventional studies showed an increase in sIgA post-vaccination or probiotic treatment.
Conclusion: Although in this review we included studies with varying methodological approaches as well as studies featuring humans and animal models, the evidence from this review indicates that mucosal sIgA offers protection against antimicrobial-resistant (AMR) bacteria colonization. Therefore, findings from this study suggest that in the quest for addressing AMR that approaches targeting mucosal immunity preventative measures should be explored through standardized trials.

CITATION

Lawal O, Olaniyi AO, Tochukwu UC, Rono C, Badmus MJ, Abdulkareem MO, et al. Mucosal Immune Markers and Their Impact on Antimicrobial Resistance: A Systematic Review. J CLIN MED KAZ. 2025;22(6):109-16. https://doi.org/10.23950/jcmk/17362

REFERENCES

  • World Health Organization. Antimicrobial resistance. 2023 Nov 21. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
  • Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, Han C, Bisignano C, Rao P, Wool E, Johnson SC, Browne AJ, Chipeta MG, Fell F, Hackett S, Hanefeld J, Etmon M, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. https://doi.org/10.1016/S0140-6736(21)02724-0.
  • Ahmed SK, Hussein S, Qurbani K, Ibrahim RH, Fareeq A, Mahmood KA, Mohamed MG. Antimicrobial resistance: Impacts, challenges, and future prospects. J Med Surg Public Health. 2024;2:100081. https://doi.org/10.1016/j.glmedi.2024.100081
  • Salam MA, Al‑Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA, Alqumber MAA. Antimicrobial resistance: A growing serious threat to global public health. Healthcare. 2023;11:1946. https://doi.org/10.3390/healthcare11131946
  • Jacobs A. The global threat of antibiotic resistance. The New York Times. 2024 Sep 26. Available from: https://www.nytimes.com/2024/09/26/health/united-nations-drug-resistance-antibiotics.html
  • Nyathi N, Ndhlovu D, Rabvukwa E, Ndudzo A. Improving antimicrobial stewardship in human health using probiotics and their derivatives. In: Probiotics and Their Derivatives – Applications in Human and Animal Health. IntechOpen; 2024. https://doi.org/10.5772/intechopen.112497
  • Corthésy B. Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces. Future Microbiol. 2010;5(5):817–829. https://doi.org/10.2217/fmb.10.39
  • Zhou X, Wu Y, Zhu Z, Lu C, Zhang C, Zeng L, Xie F, Zhang L, Zhou F. Mucosal immune response in biology, disease prevention and treatment. Signal Transduct Target Ther. 2025;10(1):7. https://doi.org/10.1038/s41392-024-02043-4
  • Oluwasola A, Otegbayo J, Ola S, Ebili H, Afolabi A, Odaibo G. Correlation of serum anti-helicobacter pylori immunoglobulin A (IgA) with histological parameters of chronic gastritis in Ibadan, Nigeria. Ann Ib Postgrad Med. 2012;10(1):18–24.
  • Kusumo PD, Bela B, Wibowo H, Munasir Z, Surono IS. Lactobacillus plantarum IS-10506 supplementation increases faecal sIgA and immune response in children younger than two years. Benef Microbes. 2019;10(3):245–252. https://doi.org/10.3920/BM2017.0178
  • Ku S, Haque MA, Jang MJ, Ahn J, Choe D, Jeon JI, Park MS. The role of Bifidobacterium in longevity and the future of probiotics. Food Sci Biotechnol. 2024;33(9):2097–2110. https://doi.org/10.1007/s10068-024-01631-y
  • Biagi E, Franceschi C, Rampelli S, Capri M, Brigidi P, Candela M. Gut microbiota and extreme longevity. Curr Biol. 2016;26(11):1480–1485. https://doi.org/10.1016/j.cub.2016.04.016
  • Rampelli S, Soverini M, D’Amico F, Barone M, Tavella T, Monti D, Capri M, Astolfi A, Brigidi P, Biagi E, Franceschi C, Turroni S, Candela M. Shotgun metagenomics of gut microbiota in humans with up to extreme longevity and the increasing role of xenobiotic degradation. mSystems. 2020;5(2):e00124‑20. https://doi.org/10.1128/mSystems.00124‑20
  • Chen Chi‑Chung, Lai Chih‑Cheng, Huang Hui‑Ling, Huang Wen‑Yu, Toh Han‑Siong, Weng Tzu‑Chieh, Chuang Yin‑Ching, Lu Ying‑Chen, Tang Hung‑Jen. Antimicrobial activity of Lactobacillus species against carbapenem‑resistant Enterobacteriaceae. Front Microbiol. 2019;10:789. https://doi.org/10.3389/fmicb.2019.00789
  • Yan Rushuang, Lu Ye, Wu Xiaoqing, Yu Peihao, Lan Peng, Wu Xueqing, Jiang Yan, Li Qi, Pi Xionge, Liu Wei, Zhou Jiancang, Yu Yunsong. Anticolonization of carbapenem‑resistant Klebsiella pneumoniae by Lactobacillus plantarum LP1812 through accumulated acetic acid in mice intestinal. Front Cell Infect Microbiol. 2021;11:804253. https://doi.org/10.3389/fcimb.2021.804253
  • Blagojevic Christina, Brown Kevin A, Diong Christina, Fridman Daniel J, Johnstone Jennie, Langford Bradley J, Lee Samantha M, MacFadden Derek R, Schwartz Kevin L, Daneman Nick. Long-term risk of infection among patients colonized with antimicrobial-resistant pathogens: a population-wide cohort study. Open Forum Infect Dis. 2024;11(12):ofae712. https://doi.org/10.1093/ofid/ofae712
  • Virgo M, Mostowy S, Ho BT. Emerging models to study competitive interactions within bacterial communities. Trends Microbiol. 2025;33(6):688–700. https://doi.org/10.1016/j.tim.2024.12.009
  • Tao L, Reese TA. Making mouse models that reflect human immune responses. Trends Immunol. 2017;38(3):181–193. https://doi.org/10.1016/j.it.2016.12.007
  • Page Matthew J, McKenzie Joanne E, Bossuyt Patrick M, Boutron Isabelle, Hoffmann Tammy C, Mulrow Cynthia D, Shamseer Larissa, Tetzlaff Jennifer M, Akl Elie A, Brennan Sue E, Chou Roger, Glanville Julie, Grimshaw Jeremy M, Hróbjartsson Asbjørn, Lalu Manoj M, Li Tianjing, Loder Elizabeth W, Mayo‑Wilson Evan, McDonald Steve, McGuinness Luke A, Stewart Lesley A, Thomas James, Tricco Andrea C, Welch Vivian A, Whiting Penny, Moher David. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71
  • Hosseini MS, Jahanshahlou F, Akbarzadeh MA, Zarei M, Vaez-Gharamaleki Y. Formulating research questions for evidence-based studies. J Med Surg Public Health. 2024;2:100046. https://doi.org/10.1016/j.glmedi.2023.100046
  • Kmet LM, Lee RC, Cook LS. Standard quality assessment criteria for evaluating primary research papers from a variety of fields. Edmonton: Alberta Heritage Foundation for Medical Research; 2004. https://doi.org/10.7939/R37M04F16
  • Silvani MI, Werder R, Perret C. The influence of blue light on sleep, performance and wellbeing in young adults: A systematic review. Front Physiol. 2022;13:943108. https://doi.org/10.3389/fphys.2022.943108
  • Wang Maopeng, Gong Shengjie, Du Shouwen, Zhu Yilong, Rong Fengjun, Pan Rongrong, Di Yang, Li Chang, Ren Dayong, Jin Ningyi. The effect of immunoregulation of Streptococcus lactis L16 strain upon Staphylococcus aureus infection. BMC Microbiol. 2017;17(1):130. https://doi.org/10.1186/s12866-017-1038-y
  • Perruzza L, Jaconi S, Lombardo G, Pinna D, Strati F, Morone D, Seehusen F, Hu Y, Bajoria S, Xiong J, Kumru OS, Joshi SB, Volkin DB, Piantanida R, Benigni F, Grassi F, Corti D, Pizzuto MS. Prophylactic Activity of Orally Administered FliD-Reactive Monoclonal SIgA Against Campylobacter Infection. Front Immunol. 2020;11:1011. https://doi.org/10.3389/fimmu.2020.01011
  • Gorain C, Khan A, Singh A, Mondal S, Mallick AI. Bioengineering of LAB vector expressing Haemolysin co-regulated protein (Hcp): a strategic approach to control gut colonization of Campylobacter jejuni in a murine model. Gut Pathog. 2021;13(1):48. https://doi.org/10.1186/s13099-021-00444-2
  • Gudaryan AA, Maschenko IS, Dorogina AS, Shyrinkin SV. Approaches in correction of some changes of the immunologic disorders in patients with rapidly progressing generalized periodontitis with different drug susceptibility of the periodontal bacteria. Medicni Perspektivi. 2020;25(4):138–146. https://doi.org/10.26641/2307-0404.2020.4.221409
  • Li S, Chen DQ, Ji L, Sun S, Jin Z, Jin ZL, Sun HW, Zeng H, Zhang WJ, Lu DS, Luo P, Zhao AN, Luo J, Zou QM, Li HB. Development of Different Methods for Preparing Acinetobacter baumannii Outer Membrane Vesicles Vaccine: Impact of Preparation Method on Protective Efficacy. Front Immunol. 2020;11:1069. https://doi.org/10.3389/fimmu.2020.01069
  • Haldar R, Dhar A, Ganguli D, Chakraborty S, Pal A, Banik G, Miyoshi SI, Das S. A candidate glycoconjugate vaccine induces protective antibodies in the serum and intestinal secretions, antibody recall response and memory T cells and protects against both typhoidal and non-typhoidal Salmonella serovars. Front Immunol. 2024;14:1304170. https://doi.org/10.3389/fimmu.2023.1304170
  • Zhang F, Bai J, Zheng Y, Liang S, Lei L, Deng X, Li W, Liu P, Yang G, Ren Y. Investigation of the Optimum Preparation of Peach Gum Polysaccharides and the In Vivo and In Vitro Therapeutic Effects on Acute Pyelonephritis. Evid Based Complement Alternat Med. 2019;2019:2729343. https://doi.org/10.1155/2019/2729343
  • Xiangchen GU, Meisi Q, Lin X, Min C, Yueyi D, Changming Z, Guihua J, Chen W, Yi W. Individualized Traditional Chinese Medicine treatment antibiotics for recurrent urinary tract infections: a multicenter, randomized controlled study. J Tradit Chin Med. 2024;44(3):524–529. https://doi.org/10.19852/j.cnki.jtcm.20231024.001
  • Li Z, Wang X, Zheng D, Han F, Li Y, Zhou H, Li J, Cui W, Jiang Y, Wang X, Xie W, Tang L. Oral-delivery Lactococcus lactis expressing cherry fusion lactoferrin peptides against infection of avian pathogenic Escherichia coli in chickens. Poult Sci. 2025;104(1):104637. https://doi.org/10.1016/j.psj.2024.104637
  • Clarkson KA, Frenck RW Jr, Dickey M, Suvarnapunya AE, Chandrasekaran L, Weerts HP, Heaney CD, McNeal M, Detizio K, Parker S, Hoeper A, Bourgeois AL, Porter CK, Venkatesan MM, Kaminski RW. Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G. mSphere. 2020;5(5):e00988-19. https://doi.org/10.1128/mSphere.00988-19
  • Shrivastava S, Agnememel AB, Ndungo E, Islam D, Liang Y, Frenck RW, Pasetti MF. Oral immunization with Shigella sonnei WRSs2 and WRSs3 vaccine strains elicits systemic and mucosal antibodies with functional anti-microbial activity. mSphere. 2024;9(3):e00419-23. https://doi.org/10.1128/msphere.00419-23
  • Strugnell R, Wijburg O. The role of secretory antibodies in infection immunity. Nat Rev Microbiol. 2010;8(8):656–667. https://doi.org/10.1038/nrmicro2384
  • Johansson MEV, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A. 2008;105(39):15064–15069. https://doi.org/10.1073/pnas.0803124105
  • Tokuhara Daisuke, Yuki Yoshikazu, Nochi Tomonori, Kodama Toshio, Mejima Mio, Kurokawa Shiho, Takahashi Yuko, Nanno Masanobu, Nakanishi Ushio, Takaiwa Fumio, Honda Takeshi, Kiyono Hiroshi. Secretory IgA-mediated protection against Vibrio cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine. Proc Natl Acad Sci U S A. 2010;107(19):8794–8799. https://doi.org/10.1073/pnas.0914121107
  • Bunker Jeffrey J, Erickson Steven A, Flynn Theodore M, Henry Carole, Koval Jason C, Meisel Marlies, Jabri Bana, Antonopoulos Dionysios A, Wilson Patrick C, Bendelac Albert. Natural polyreactive IgA antibodies coat the intestinal microbiota. Science. 2017;358(6361):eaan6619. https://doi.org/10.1126/science.aan6619
  • van Dalen R, Elsherbini AMA, Harms M, Perret M, Zaat SAJ, de Steenhuijsen Piters WAA. Secretory IgA impacts the microbiota density in the human nose. Microbiome. 2023;11:233. https://doi.org/10.1186/s40168-023-01675-y
  • Ivanov Ivaylo I, Atarashi Koji, Manel Nicolas, Brodie Eoin L, Shima Tatsuichiro, Karaoz Ulas, Wei Dongguang, Goldfarb Katherine C, Santee Clark A, Lynch Susan V, Tanoue Takeshi, Imaoka Akemi, Itoh Kikuji, Takeda Kiyoshi, Umesaki Yoshinori, Honda Kenya, Littman Dan R. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139(3):485–498. https://doi.org/10.1016/j.cell.2009.09.033
  • Atarashi Koji, Tanoue Takeshi, Oshima Kenshiro, Suda Wataru, Nagano Yuji, Nishikawa Hiroyoshi, Fukuda Shinji, Saito Takuro, Narushima Seiko, Hase Koji, Kim Sangwan, Fritz Joëlle V, Wilmes Paul, Ueha Satoshi, Matsushima Kouji, Ohno Hiroshi, Olle Bernat, Sakaguchi Shimon, Taniguchi Tadatsugu, Morita Hidetoshi, Hattori Masahira, Honda Kenya. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013;500(7461):232–236. https://doi.org/10.1038/nature12331
  • Palm Noel W, de Zoete Mark R, Cullen Travis W, Barry Nicholas A, Stefanowski Jared, Hao Lili, Degnan Patrick H, Hu Ji, Peter Irene, Zhang Wen. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell. 2014;158(5):1000–1010. https://doi.org/10.1016/j.cell.2014.08.006
  • Pietrzak B, Tomela K, Olejnik-Schmidt A, Mackiewicz A, Schmidt M. Secretory IgA in intestinal mucosal secretions as an adaptive barrier against microbial cells. Int J Mol Sci. 2020;21(23):9254. https://doi.org/10.3390/ijms21239254
  • Hodgkinson Alison J, Cakebread Julie, Callaghan Megan, Harris Paul, Brunt Rachel, Anderson Rachel C, Armstrong Kelly M, Haigh Brendan. Comparative innate immune interactions of human and bovine secretory IgA with pathogenic and non‑pathogenic bacteria. Dev Comp Immunol. 2017;68:21–25. https://doi.org/10.1016/j.dci.2016.11.012
  • Gorrell Rebecca J, Wijburg Odilia L C, Pedersen John S, Walduck Anna K, Kwok Terry, Strugnell Richard A, Robins‑Browne Roy M. Contribution of secretory antibodies to intestinal mucosal immunity against Helicobacter pylori. Infect Immun. 2013;81(10):3880–3893. https://doi.org/10.1128/IAI.01424-12
  • Eldridge Gary R, Hughey Heidi, Rosenberger Lois, Martin Steven M, Shapiro Andrew M, D’Antonio Elizabeth, Krejci Kent G, Shore Neal, Peterson James, Lukes Andrea S, Starks Courtney M. Safety and immunogenicity of an adjuvanted Escherichia coli adhesin vaccine in healthy women with and without histories of recurrent urinary tract infections: results from a first‑in‑human phase 1 study. Hum Vaccin Immunother. 2021;17(5):1262–1270.https://doi.org/10.1080/21645515.2020.1834807
  • Nickel JC, Kelly K-L, Griffin A, Elterman DS, Clark-Pereira J, Doiron RC. MV140 sublingual vaccine reduces recurrent urinary tract infection in women: Results from the first North American clinical experience study. Can Urol Assoc J. 2023;18(2):25–31. https://doi.org/10.5489/cuaj.8455